Stay updated on Selitrectinib Safety Study in Children and Adults Clinical Trial
Sign up to get notified when there's something new on the Selitrectinib Safety Study in Children and Adults Clinical Trial page.

Latest updates to the Selitrectinib Safety Study in Children and Adults Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check84 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check99 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check106 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to Selitrectinib Safety Study in Children and Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selitrectinib Safety Study in Children and Adults Clinical Trial page.